We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Orthofix Medical
OFIX
$481M
| $984K | 0.09% |
32,732
-10,879
| -25% | -$319K |
|
|
VER
352
DELISTED
VEREIT, Inc.
VER
| $983K | 0.09% |
+21,726
| New | +$1.06M |
|
353
Ribbon Communications
RBBN
$359M
| $979K | 0.09% |
49,339
-16,096
| -25% | -$285K |
|
|
PAMT
354
PAMT Corp
PAMT
$356M
| $977K | 0.09% |
75,424
-33,424
| -31% | -$365K |
|
355
Orion Group Holdings
ORN
$503M
| $972K | 0.09% |
87,922
+70,567
| +407% | +$738K |
|
356
BlackRock Multi-Sector Income Trust
BIT
$694M
| $971K | 0.09% |
57,874
-9,346
| -14% | -$163K |
|
357
Reading International Class A
RDI
$33.6M
| $971K | 0.09% |
+73,231
| New | +$797K |
|
358
Matrix Service
MTRX
$347M
| $970K | 0.09% |
43,474
-115,559
| -73% | -$2.6M |
|
|
HMHC
359
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $965K | 0.09% |
+46,586
| New | +$930K |
|
|
ITG
360
DELISTED
Investment Technology Group Inc
ITG
| $962K | 0.09% |
+46,183
| New | +$863K |
|
|
CPRX
361
DELISTED
Catalyst Pharmaceutical
CPRX
| $958K | 0.09% |
322,662
+93,622
| +41% | +$257K |
|
|
LNW
362
DELISTED
Light & Wonder
LNW
| $956K | 0.09% |
+75,080
| New | +$904K |
|
|
MRC
363
DELISTED
MRC Global
MRC
| $956K | 0.09% |
63,125
+22,773
| +56% | +$443K |
|
|
POM
364
DELISTED
PEPCO HOLDINGS, INC.
POM
| $956K | 0.09% |
35,511
-26,487
| -43% | -$718K |
|
365
Jack in the Box
JACK
$299M
| $952K | 0.09% |
11,905
-44,623
| -79% | -$3.25M |
|
|
CBPX
366
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $951K | 0.09% |
53,650
+38,390
| +252% | +$609K |
|
367
Enterprise Financial Services Corp
EFSC
$2.4B
| $949K | 0.09% |
48,110
+34,822
| +262% | +$645K |
|
|
STML
368
DELISTED
Stemline Therapeutics, Inc.
STML
| $947K | 0.09% |
55,507
-64,605
| -54% | -$932K |
|
|
CCC
369
DELISTED
Calgon Carbon Corp
CCC
| $947K | 0.09% |
45,589
-201,623
| -82% | -$4.09M |
|
|
ADVS
370
DELISTED
Advent Software Inc
ADVS
| $945K | 0.09% |
30,843
+343
| +1% | +$11K |
|
|
LVNTA
371
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $944K | 0.09% |
+25,024
| New | +$874K |
|
372
Paycom
PAYC
$7.05B
| $943K | 0.09% |
35,827
+18,445
| +106% | +$408K |
|
373
LCI Industries
LCII
$2.52B
| $942K | 0.09% |
18,451
-50,619
| -73% | -$2.37M |
|
|
AMED
374
DELISTED
Amedisys
AMED
| $941K | 0.09% |
+32,048
| New | +$791K |
|
|
CVGW
375
DELISTED
Calavo Growers
CVGW
| $940K | 0.09% |
+19,865
| New | +$912K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.